Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,596 | 446 | 99.7% |
| Education | $22.73 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $876.69 | 62 | $0 (2024) |
| Amgen Inc. | $807.56 | 56 | $0 (2024) |
| Novo Nordisk Inc | $794.53 | 62 | $0 (2024) |
| Amarin Pharma Inc. | $547.03 | 13 | $0 (2021) |
| Merck Sharp & Dohme LLC | $466.27 | 40 | $0 (2024) |
| Lilly USA, LLC | $428.61 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $422.77 | 28 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $419.18 | 26 | $0 (2024) |
| PFIZER INC. | $308.27 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $254.92 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $736.91 | 41 | AstraZeneca Pharmaceuticals LP ($146.34) |
| 2023 | $645.85 | 41 | GlaxoSmithKline, LLC. ($106.19) |
| 2022 | $782.62 | 56 | GlaxoSmithKline, LLC. ($180.67) |
| 2021 | $497.78 | 36 | GlaxoSmithKline, LLC. ($85.45) |
| 2020 | $370.39 | 26 | GlaxoSmithKline, LLC. ($86.87) |
| 2019 | $962.13 | 71 | Amgen Inc. ($209.21) |
| 2018 | $1,203 | 78 | Amarin Pharma Inc. ($260.26) |
| 2017 | $1,421 | 100 | SANOFI-AVENTIS U.S. LLC ($288.44) |
All Payment Transactions
449 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: VACCINE | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 11/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Biological | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: VACCINES | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Diabetes Care | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Bone Health | ||||||
| 08/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Bone Health | ||||||
| 07/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Obesity | ||||||
| 07/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Diabetes Care | ||||||
| 06/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Oncology | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,225 | 3,329 | $238,785 | $143,399 |
| 2022 | 14 | 1,231 | 3,228 | $218,080 | $141,688 |
| 2021 | 17 | 1,231 | 4,026 | $223,805 | $156,429 |
| 2020 | 16 | 1,358 | 4,391 | $232,175 | $151,168 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 254 | 254 | $46,990 | $31,280 | 66.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 15 | 1,680 | $43,800 | $30,744 | 70.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 269 | 475 | $51,330 | $25,380 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 356 | $49,840 | $25,374 | 50.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2023 | 92 | 92 | $7,820 | $6,614 | 84.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 30 | $8,300 | $6,302 | 75.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 94 | 122 | $7,320 | $4,462 | 61.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $4,830 | $3,628 | 75.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 87 | 87 | $3,915 | $2,562 | 65.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $2,625 | $2,371 | 90.3% |
| 69200 | Removal of foreign body in ear canal | Office | 2023 | 27 | 39 | $4,680 | $1,818 | 38.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 15 | 28 | $3,080 | $1,195 | 38.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 73 | $2,555 | $1,173 | 45.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 25 | $1,250 | $251.85 | 20.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 30 | $450.00 | $242.59 | 53.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 246 | 246 | $39,485 | $31,149 | 78.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 302 | 611 | $58,170 | $29,286 | 50.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 17 | 1,560 | $36,200 | $26,570 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 281 | $39,070 | $23,000 | 58.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 118 | 122 | $9,665 | $8,349 | 86.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 25 | 29 | $7,830 | $6,175 | 78.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 26 | 26 | $4,550 | $4,216 | 92.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 80 | 117 | $7,020 | $4,133 | 58.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 114 | 117 | $4,615 | $3,312 | 71.8% |
| 69200 | Removal of foreign body in ear canal | Office | 2022 | 28 | 42 | $5,040 | $1,972 | 39.1% |
About Dr. Neal Davis, DO
Dr. Neal Davis, DO is a Family Medicine healthcare provider based in Carbondale, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437152113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neal Davis, DO has received a total of $6,619 in payments from pharmaceutical and medical device companies, with $736.91 received in 2024. These payments were reported across 449 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($6,596).
As a Medicare-enrolled provider, Davis has provided services to 5,045 Medicare beneficiaries, totaling 14,974 services with total Medicare billing of $592,685. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Carbondale, PA
- Active Since 05/24/2005
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437152113
Products in Payments
- TRELEGY ELLIPTA (Drug) $629.68
- Vascepa (Drug) $547.03
- Victoza (Drug) $309.93
- Prolia (Biological) $287.96
- Aimovig (Biological) $244.96
- Ozempic (Drug) $234.62
- JANUVIA (Drug) $226.66
- JARDIANCE (Drug) $224.77
- TOUJEO (Drug) $213.55
- ELIQUIS (Drug) $179.78
- FARXIGA (Drug) $173.63
- TRULICITY (Drug) $172.11
- EVENITY (Biological) $139.31
- Xolair (Biological) $124.99
- AIRSUPRA (Drug) $118.94
- Livalo (Drug) $109.62
- VERQUVO (Drug) $106.80
- ENTRESTO (Drug) $106.74
- Otezla (Drug) $105.30
- Cologuard Collection Kit (Device) $104.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Carbondale
Dr. Matthew Haley, Do, DO
Family Medicine — Payments: $34,881
Dr. David Penn, M.d, M.D
Family Medicine — Payments: $3,972
Dr. Terry Luma, M.d, M.D
Family Medicine — Payments: $3,637
Mr. Roger Jones, Md, MD
Family Medicine — Payments: $3,460
Dr. Neda Danniel, Md, MD
Family Medicine — Payments: $3,413
Dr. Ana Migone, M.d, M.D
Family Medicine — Payments: $3,378